All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • OG-6219Phase 21 trial

    Organon and Co · Endometriosis

  • OHB-607Mecasermin RinfabatePhase 21 trial

    OHB Neonatology Ltd. · Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage

  • OKI-179Phase 21 trial

    OnKure, Inc. · RAS Mutation, NRAS Gene Mutation, Melanoma

  • OLX72021Phase 21 trial

    Olix Pharmaceuticals, Inc. · Androgenetic Alopecia (AGA)

  • OM-85Phase 21 trial

    OM Pharma SA · Recurrent Wheezing, Wheezing Lower Respiratory Illness

  • OMT-28Phase 21 trial

    Omeicos Therapeutics GmbH · Primary Mitochondrial Disease

  • ONO-4538HSCPhase 21 trial

    Ono Pharmaceutical Co., Ltd. · Pediatric Malignant Solid Tumor and Epithelioid Sarcoma

  • ONO-4915Phase 21 trial

    Ono Pharmaceutical Co., Ltd. · Sjogren's Disease

  • ONO-7703Phase 21 trial

    Ono Pharmaceutical Co., Ltd. · Pan-tumor

  • OpCT-001Phase 21 trial

    BlueRock Therapeutics · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), Usher Syndrome

  • OPK-88006Phase 21 trial

    OPKO Health, Inc. · MASH

  • OPM-101Phase 21 trial

    Oncodesign Precision Medicine · Advanced Melanoma

  • OPT101Phase 21 trial

    Op-T LLC · Type I Diabetes

  • OR502Phase 21 trial

    OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm

  • ORIC-114Phase 21 trial

    ORIC Pharmaceuticals · Solid Tumors

  • OriCAR-017Phase 21 trial

    OriCell Therapeutics Co., Ltd. · Relapsed and/or Refractory Multiple Myeloma

  • ORJ-001Phase 21 trial

    Oorja Bio, Inc. · Idiopathic Pulmonary Fibrosis

  • OrticumabMLDL1278a, BI204Phase 21 trial

    Abcentra · Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation

  • OSE-279Phase 21 trial

    OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)

  • OST31-164Phase 21 trial

    Emerald Clinical Inc. · Bone Cancer

  • OTP-01Phase 21 trial

    Ottimo Pharma Limited · Advanced Solid Tumors

  • OVX836Phase 21 trial

    Osivax · Influenza

  • OXU-001DEXAspheresPhase 21 trial

    Oxular Limited · Diabetic Macular Edema

  • PAL-119Phase 21 trial

    Paulex Bio Inc. · Healthy Volunteers and Diabetes Participants

  • PALI-2108Phase 21 trial

    Palisade Bio · Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis

  • paxalisibSVG103Phase 21 trial

    Sovargen · Focal Cortical Dysplasia, Tuberous Sclerosis Complex (TSC), Hemimegalencephaly

  • PBGM01Phase 21 trial

    Gemma Biotherapeutics · GM1 Gangliosidosis, GM1 Gangliosidosis, Type I, GM1 Gangliosidosis, Type 2

  • PBP1510Phase 21 trial

    Prestige Biopharma Limited · Pancreatic Cancer

  • PBSS1113Phase 21 trial

    Chaser Therapeutics, Inc. · Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)

  • PCV1515-valent pneumococcal conjugate vaccinePhase 21 trial

    Pfizer · Pneumococcal Disease

  • PDC-1421Phase 21 trial

    BioLite, Inc. · Major Depressive Disorder

  • PDFE-2304Phase 21 trial

    PDFE Pharma Innovations FZCO · Alopecia, Androgenetic, Baldness, Androgenetic Alopecia (AGA)

  • PE0105Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors

  • PE0116Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors

  • PegenzileukinSAR444245Phase 21 trial

    Sanofi · Plasma Cell Myeloma Refractory

  • PEGPH20Phase 21 trial

    Roche (Genentech) · Pancreatic Adenocarcinoma

  • PempulimabPhase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Nasopharyngeal Carcinoma

  • PepinemabPhase 21 trial

    Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma

  • PF-0704091Phase 21 trial

    Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer

  • PF-07264660Phase 21 trial

    Pfizer · Atopic Dermatitis

  • PF-07328948Phase 21 trial

    Pfizer · Heart Failure

  • PF-07868489Phase 21 trial

    Pfizer · Pulmonary Arterial Hypertension

  • PF-07976016Phase 21 trial

    Pfizer · Obesity

  • PF-08049820Phase 21 trial

    Pfizer · Atopic Dermatitis, Eczema, Atopic

  • PF-08154225Phase 21 trial

    Pfizer · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis

  • PF-08653945Phase 21 trial

    Pfizer · Overweight, Obesity, Overweight and/or Obesity

  • PG043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • Genelux Corporation · Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer

  • PIPE-307Phase 21 trial

    Johnson & Johnson (Janssen) · Relapsing Remitting Multiple Sclerosis

  • PIPE-791Phase 21 trial

    Contineum Therapeutics · Idiopathic Pulmonary Fibrosis

NewerPage 64 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.